Chapter 4 - The Paper Trail of Sins
The word *prison* hung in the sterile air of the consultation room like a toxic gas. Vincent stayed on his knees, his hands suspended in mid-air, his wet suit jacket bunching awkwardly around his shoulders. A sickly, disbelieving smirk flickered across his face—the desperate reflex of a white-collar predator who had spent his entire career insulating himself behind corporate veils and high-priced retainers.
“Prison?” Vincent scoffed, climbing slowly to his feet, wiping his damp palms against his trousers. He tried to pull his executive posture back together, squaring his shoulders, though his eyes remained wild. “Be serious, Claire. Bigamy is a misdemeanor in Illinois. It carries a fine and probation at most. I’ll hire Kirkland & Ellis. The civil suit will be settled out of court, Rebecca will get an NDA settlement, and the public will never hear a whisper of this. You’re hurt, you’re furious—you have every right to be. But don't make legal threats you can't back up.”
Eleanor Vance didn't even blink. She walked over to the laminate table, pulled out a pair of silver reading glasses from her pocket, and clicked her gold Montblanc pen against the wood.
“You’re entirely correct, Vincent,” Eleanor purred, her tone dripping with venomous amusement. “Bigamy is rarely prosecuted with prison time. Which is why Claire and I didn't spend the last seventy-two hours looking at your romantic indiscretions. We spent them looking at *Aegis BioSciences*.”
Every muscle in Vincent’s neck locked instantly. The waxy gray color returned to his face with a vengeance.
“Aegis is an independent biotech startup,” Vincent muttered, his voice dropping into a low, defensive growl. “It has nothing to do with this marriage. Vanguard provided mezzanine financing. It’s entirely segregated.”
“Is it?” Claire stepped forward, her arms crossed over her chest. “Because three months ago, I was reviewing the annual grant distributions for the Mitchell Foundation’s clinical trials at Cook County. I noticed an anomaly. A multi-center Phase III trial for an experimental synthetic neuro-steroid aimed at preventing preeclampsia—*compound Aegis-409*—was listed as having received institutional review board approval under my forged digital signature.”
Vincent swallowed hard. “That was an administrative clerical error by the trial coordinators—”
“Do not interrupt me,” Claire hissed, the authority in her voice slamming into him like a physical blow. “I pulled the lab manifests from the third-party clinical supply house in Indiana. The shipments weren't going to the hospital’s research pharmacy. They were being delivered directly to a private medical suite registered under your name in Oakbrook.”
Eleanor Vance turned a page in the thick legal binder, angling a high-resolution bank audit toward Vincent.
“For the past two years, Vincent,” Eleanor explained, her voice steady and lethal, “you have been embezzling from the Mitchell Family Endowment—funds intended for indigent pediatric care—and funneling them through shell companies in Nevis and Delaware to keep Aegis BioSciences afloat. The company was hemorrhaging cash. The clinical trials had been rejected by the FDA twice due to acute maternal toxicity in primate models. But you had personal stock options worth forty million dollars tied to Aegis going public before the fourth quarter.”
Vincent’s breathing had become shallow and ragged. “You have no proof I directed those transactions.”
“We didn't,” Claire said, taking a step toward him, her gaze searing into his conscience. “Until tonight.”
She reached down and tapped a single document in the folder. It was a toxicology screening requisition form from Cook County Hospital’s urgent pathology lab, timestamped 9:42 PM—less than an hour ago.
“When Rebecca was brought in,” Claire continued, her voice trembling slightly with the horror of what she was saying, “she had severe uterine tetany, elevated transaminases, and microvascular hemorrhaging. Those aren't standard symptoms of spontaneous placental abruption. That is acute toxicity caused by an unapproved synthetic progesterone analog.”
Vincent’s eyes darted wildly toward the door, as if calculating the distance to the exit.
“I ran her blood work under an emergency stat protocol,” Claire whispered, her eyes burning with pure, unadulterated revulsion. “Rebecca has massive concentrations of Aegis-409 in her bloodstream. *You were dosing her, Vincent.*”
“No!” Vincent shouted, lunging forward and slamming his open palms onto the table. “No! That is a lie! I was trying to save our baby! Rebecca had two miscarriages last year—her cervix was incompetent, her progesterone levels were plummeting! The doctors said the pregnancy wasn't viable! I gave her the compound to save the child! It was formulated to reinforce the uterine lining!”
“It was an untested, toxic chemical rejected by the FDA for causing lethal vascular spasms in pregnant test subjects!” Claire screamed back, tears of sheer rage finally spilling over her eyelashes. “You turned the woman you called your wife into an unauthorized human guinea pig to save your failing stock options! If that baby had died tonight, Vincent, you wouldn't just be facing fraud and grand larceny. You would be facing depraved-heart murder!”
Vincent collapsed back into the chair, burying his face in his trembling hands. The magnitude of what he had done—the labyrinth of lies, financial theft, and illegal medical experimentation—had finally collapsed inward, crushing him beneath the rubble.
“Does Rebecca know?” Vincent whimpered into his hands. “Does she know what you found?”
Claire looked down at the ruined shell of the man she had loved for nearly a decade.
May you like
“No,” Claire said quietly. “Not yet. But I am going to walk down to her room right now and tell her every single detail. Because unlike you, Vincent... I don't hide the truth from women.”
***
